Full Text View
Tabular View
No Study Results Posted
Related Studies
A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
This study has been completed.
Study NCT00642148   Information provided by GlaxoSmithKline

First Received on March 17, 2008.   Last Updated on March 10, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Obstructive Airway Disease
Additional conditions recognized in this trial
Chronic Disease
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
More general conditions related to this trial
Disease Attributes
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
GW856553
Placebo
Seretide
Additional drug interventions recognized in this trial
Fluticasone, salmeterol drug combination
More general drug interventions related to this trial
Autonomic Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sympathomimetics
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services